Molecular cloning and characterization of another leukotriene B4 receptor

被引:0
|
作者
Kamohara, M [1 ]
Takasaki, J [1 ]
Matsumoto, M [1 ]
Saito, T [1 ]
Ohishi, T [1 ]
Ishii, H [1 ]
Furuichi, K [1 ]
机构
[1] Yamanouchi Pharmaceut Co Ltd, Inst Drug Discovery Res, Mol Med Labs, Tsukuba, Ibaraki 3058585, Japan
关键词
D O I
10.1074/jbc.C000382200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Leukotriene B-4 is a potent lipid mediator known to be implicated mainly in inflammatory actions. Previous pharmacological studies indicated the existence of only one class of G protein-coupled receptor for leukotriene B-4, for which a candidate gene, namely BLT, had been identified. Here we report the isolation of another gene encoding a functional G protein-coupled receptor for leukotriene B-4, named JULF2. JULF2 is a novel G protein-coupled receptor of 358 amino acids that shares 36.6% amino acid identity with human BLT, According to genomic information, the JULF2 gene is located on the chromosome 14, about 4 kilobases upstream of the BLT gene. During screening of endogenous ligands for JULF2, we found that leukotriene B-4 induced inhibition of forskolin-stimulated cAMP accumulation in Chinese hamster ovary cells, stably expressing JULF2, Additionally, Chinese hamster ovary cells expressing exogenous JULF2 showed chemotactic responses with leukotriene B-4 in a pertussis toxin-sensitive manner. A large amount of JULF2 mRNA was detected in the human spleen and the peripheral blood leukocytes. Furthermore, JULF2 mRNA was expressed in mononuclear lymphocytes, in which BLT mRNA was barely detected. The discovery of this second leukotriene B-4 receptor will eventually lead to a better understanding of the classification of leukotriene B-4 receptors and reconsideration of the pathophysiological role of leukotriene B-4.
引用
收藏
页码:27000 / 27004
页数:5
相关论文
共 50 条
  • [31] Characterization of the cloned guinea pig leukotriene B4 receptor:: comparison to its human orthologue
    Boie, Y
    Stocco, R
    Sawyer, N
    Greig, GM
    Kargman, S
    Slipetz, DM
    O'Neill, GP
    Shimizu, T
    Yokomizo, T
    Metters, KM
    Abramovitz, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 380 (2-3) : 203 - 213
  • [32] Expression, purification and characterization of leukotriene B4 receptor, BLT1 in Pichia pastoris
    Hori, Tetsuya
    Sato, Yo
    Takahashi, Naoko
    Takio, Koji
    Yokomizo, Takehiko
    Nakamura, Motonao
    Shimizu, Takao
    Miyano, Masashi
    PROTEIN EXPRESSION AND PURIFICATION, 2010, 72 (01) : 66 - 74
  • [33] Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor
    Sarau, HM
    Ames, RS
    Chambers, J
    Ellis, C
    Elshourbagy, N
    Foley, JJ
    Schmidt, DB
    Muccitelli, RM
    Jenkins, O
    Murdock, PR
    Herrity, NC
    Halsey, W
    Sathe, G
    Muir, AI
    Nuthulaganti, P
    Dytko, GM
    Buckley, PT
    Wilson, S
    Bergsma, DJ
    Hay, DWP
    MOLECULAR PHARMACOLOGY, 1999, 56 (03) : 657 - 663
  • [34] NEW VISTAS IN INFLAMMATION RESEARCH - THE LEUKOTRIENE B4 RECEPTOR ANTAGONISTS
    DJURIC, SW
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 204 : 3 - MEDI
  • [35] Targeting leukotriene B4 in inflammation
    Di Gennaro, Antonio
    Haeggstrom, Jesper Z.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (01) : 79 - 93
  • [36] Metabolism and receptors of leukotriene B4
    Yokomizo, T
    SEIKAGAKU, 2002, 74 (09): : 1139 - 1147
  • [37] Role of leukotriene B4 receptor signaling in human preadipocyte differentiation
    Hirata, Kae
    Katayama, Kazufumi
    Nakajima, Atsushi
    Takada, Kenji
    Kamisaki, Yoshinori
    Wada, Koichiro
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 429 (3-4) : 197 - 203
  • [38] CHIRAL SYNTHESIS OF LEUKOTRIENE B4
    Yan Fang WANG
    Jin Cui LI
    Yu Lin WU
    (State key Laboratory of Bio-organic and Natural Products
    Li Lan SHI
    Yao Zeng HUANG (Laboratory
    Chinese Chemical Letters, 1994, (06) : 459 - 460
  • [39] Biochemical and immunological characterization of a novel monoclonal antibody against mouse leukotriene B4 receptor 1
    Sasaki, Fumiyuki
    Koga, Tomoaki
    Saeki, Kazuko
    Okuno, Toshiaki
    Kazuno, Saiko
    Fujimura, Tsutomu
    Ohkawa, Yasuyuki
    Yokomizo, Takehiko
    PLOS ONE, 2017, 12 (09):
  • [40] In vitro and in vivo pharmacological characterization of BIIL 284, a novel and potent leukotriene B4 receptor antagonist
    Birke, FW
    Meade, CJ
    Anderskewitz, R
    Speck, GA
    Jennewein, HM
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 297 (01): : 458 - 466